Latest News about AZN
Recent news which mentions AZN
Benzinga's Top Ratings Upgrades, Downgrades For January 15, 2021
Today 10:07 EST
From Benzinga
From Benzinga
‘Lifeline to workers’: Why Biden’s call for a $1.9 billion COVID-19 rescue package has NOT come a moment too soon
January 14, 2021
From MarketWatch
From MarketWatch
How Soon Could AstraZeneca's COVID Vaccine Be Available in the U.S.?
January 14, 2021
Tickers
AZN
From Motley Fool
COVID-19 infection likely to provide immunity for at least 5 months, but people may still transmit virus, study finds
January 14, 2021
From MarketWatch
My Top 3 Large-Cap Stocks to Own in 2021
January 14, 2021
From Motley Fool
5 Large-Cap Stocks That'll Make You Richer in 2021
January 14, 2021
From Motley Fool
From MarketWatch
From MarketWatch
AstraZeneca–Oxford COVID-19 shot could be authorized Jan. 29, says EU medical regulator
January 12, 2021
From MarketWatch
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
Here Are the Next COVID Vaccines About to Cross the Finish Line
January 12, 2021
From Motley Fool
From Benzinga
EasyJet lands $1.87 billion state-backed loan as it looks to ease COVID cash crunch
January 11, 2021
From MarketWatch
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
January 09, 2021
From Benzinga
Better Coronavirus Stock: AstraZeneca vs. Pfizer
January 09, 2021
From Motley Fool
Biden plans to distribute COVID-19 vaccine doses immediately
January 08, 2021
From MarketWatch
From MarketWatch
AstraZeneca has scope to increase dividend by 25%, key broker says, as broader FTSE 100 edges lower
January 08, 2021
From MarketWatch
AstraZeneca has scope to increase dividend by 25%, key broker says, as broader FTSE 100 edges lower
January 08, 2021
From MarketWatch
From MarketWatch
Moderna Has Big Plans For 2021
January 07, 2021
From Benzinga
Third vaccine could be approved for U.K. within weeks boosting mass immunisation drive, top scientist says
January 07, 2021
From MarketWatch
Is AstraZeneca Stock a Buy?
January 07, 2021
From Motley Fool
2 Top Value Stocks to Own in 2021
January 06, 2021
From Motley Fool
3 Big Potential Catalysts for Moderna in 2021
January 06, 2021
From Motley Fool
3 Top Stocks That'll Make You Richer in January (and Beyond)
January 06, 2021
From Motley Fool
From Benzinga
Is Peloton Stock a Buy?
January 05, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC